The Cost Of Cancer Drugs: Patients Vastly Overpaying For Treatments, Study Finds
Some companies charge 600 times the cost of producing TKIs, a type of cancer treatment.
Pfizer: UK Competition and Markets Authority Accuses Pharmaceutical Firm of Overcharging
Pharmaceutical firms Flynn and Pfizer have been accused of “unfair prices” for one of their drugs by the U.K. Competition and Markets Authority.
Prozac And Paxil Antidepressants Linked To Birth Defects: Study
Heart problems and defects in the formation of brain and skull were linked to antidepressants such as Prozac and Paxil.
Pfizer Unveils Single Packs For Viagra In Move To Refresh Aging Brand
The popular erectile dysfunction drug has been repackaged into single-dose servings that should aid on-the-go use.
-
Earnings Buzz: Pfizer Inc (PFE), Merck & Co Inc (MRK), Bristol-Myers Squibb Co (BMY)
-
Earnings Buzz: Apple Inc (AAPL), Twitter Inc (TWTR), LinkedIn Corp (LNKD), Pfizer Inc (PFE)
-
11 Blockbuster 'Drugs To Watch' In 2015
-
Antibiotic Resistance: Why Aren’t Drug Companies Developing New Medicines To Stop Superbugs?
More news
Wisconsin Governor Scott Walker Backs Anti-Union Bill In State Senate: State Inches Toward Right-To-Work
In an about-face, Wisconsin Governor Scott Walker says he supports a "right to work" bill that would cripple organized labor.
Dow Jones Industrial Average Leaps 100 Points After Pfizer Inc (PFE) Buys Hospira Inc (HSP) For $15B
Pharmaceutical giant Pfizer helped boost the Dow Thursday after it bought injectable drug provider Hospira for $15 billion.
Pfizer To Acquire Hospira, Maker of Injectables and Biosimilars, For $17 Billion
It's the first major deal for the drug company since its failed attempt to acquire AstraZeneca last year.
Pfizer Inc (PFE) Earns FDA Approval For Breast Cancer Drug
Pfizer Inc. has received approval for a new drug to treat advanced breast cancer, which could become one of the company's most lucrative labels.
Pfizer Unlikely To Make New Bid For AstraZeneca: Swedish Newspaper
"I can't say it will never happen, but the probability that Pfizer returns is much less," the AstraZeneca CEO tells a Swedish newspaper.
Merck Tries To Close Deal To Acquire Cubist Pharmaceuticals For More Than $7B
The deal would help expand its hold in the antibiotics sector and get access to Cubist's medicines, mostly used in hospitals.
Investor William Ackman Buys $2B Stake in Zoetis, Animal-Health Company
The animal-health sector has been active in the recent mergers-and-acquisitions boom
Pfizer's $11B Buyback Plan Deflates AstraZeneca Bid Hopes
Pfizer, which has a market valuation of about $180 billion, earlier this year failed in its $118 billion bid to buy British rival AstraZeneca.
GlaxoSmithKline Shares Jump On Upbeat Earnings News, Cost-Cutting Plans
The U.K.’s biggest drugmaker announced big plans for cost-cutting and its HIV research arm on Wednesday.
Becton Dickinson To Buy CareFusion For $12B In Cash, Stock
The acquisition, recommended by the boards of both companies, would aim to combine the two U.S.-based companies' complementary products.
Viagra’s New Ad Campaign Targets Women
A new print and TV ad campaign for the erectile dysfunction drug Viagra features a woman for the first time -- and no men.
Minecraft, Nokia, Skype: How Microsoft Buys Overseas Companies To Avoid US Taxes
American tech companies continue to use offshore profits to expand their portfolios rather than repatriate funds.
Germany's Merck To Buy Sigma-Aldrich For $17B To Boost Lab Supplies Operation
Merck, which has been hit by several drug development failures, wants its own pharmaceuticals business to remain a medium-sized entity.
Roche To Buy US Biotech Firm InterMune For $8.3B
The acquisition would be Roche's largest since 2009, when it bought out the remaining stake it did not own in Genentech for about $47 billion.
Pfizer Sees Spike In Lawsuits Against Cholesterol Drug Lipitor, Up To 1,000 Cases In 5 Months
The 1,000 cases filed so far represent nearly 4,000 women, and the plaintiffs' lead lawyer estimates the number of cases can rise ten-fold.
Mergers & Acquisitions At 7-Year High
Strong stock prices and cheap money combine to drive buyouts to seven-year high.
Insurers Scrutinize Drug Costs After $84,000 Sovaldi Surprise
Sales of Sovaldi, which cures hepatitis C in 12 weeks, hit a record-breaking $2.3 billion within a few weeks.
Pfizer Gives Up On AstraZeneca Deal After Offer Is Refused
The merger would have restored Pfizer as the world's largest drugmaker by sales.
AstraZeneca Rejects Pfizer's Take-It-Or-Leave-It Offer
Pfizer wants to create the world's largest drugs company, with a headquarters in New York but a tax base in Britain.
Pfizer Raises Bid For AstraZeneca To $117 Billion
Pfizer said it would walk away if AstraZeneca did not accept it.
US Drug Companies Take Merger Route To Avoid Taxes, Compensate For Patent Expirations, Respond To Falling Healthcare Spending
Abbott, Novartis and Pfizer are all looking to buy their way to cost savings.
AstraZeneca Leaves Door Ajar To Pfizer, Despite Hurdles
AstraZeneca's boss said on Wednesday he would engage with Pfizer if the price was right.
Pages
- Promoted in Coronavirus
- 1
- 2
- 3
- 4
- 5
Editor's pick
-
Trump Clashes With Fed Chief Powell Over Interest Rates
-
Where Are All The Aliens?: Fermi's Paradox Explained
-
Silent Killing Fields 50 Years On From Khmer Rouge Atrocities
-
Global Trade Uncertainty Could Have 'Severe Negative Consequences': WTO Chief
-
US-China Trade War Claims New Victim: Boeing Stock Slides—Here's What To Expect
-
Trump Says Ball In China's Court On Tariffs
